<DOC>
	<DOC>NCT01379560</DOC>
	<brief_summary>The purpose of this study is to determine the pharmacodynamics of ocular blood flow measurements with multiple drop unoprostone isopropyl administration versus placebo in subjects with dry age-related macular degeneration (AMD).</brief_summary>
	<brief_title>A Study to Evaluate the Ocular Blood Flow Effects of Unoprostone Isopropyl in Adults With Dry Age-related Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Isopropyl unoprostone</mesh_term>
	<mesh_term>Dinoprost</mesh_term>
	<criteria>Age ≥ 50 years at screening Ametropy ≤ 3 diopters Clear ocular media Visual acuity in the study eye &gt; 20/40 Presence of any ocular condition in the study eye (other than AMD) that may progress during the course of the study and could affect central vision, or other ocular conditions that may be a confounding factor in this study Blood donation during the previous 3 weeks Current smoker or a history of smoking within 5 years of enrollment Treatment with protocolspecified prohibited concomitant medications Prior exposure to Rescula (unoprostone isopropyl) and or a known sensitivity to any of the components of the study medication (e.g. benzalkonium chloride)</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>